Literature DB >> 16079102

A comparison of the defective granulopoiesis in childhood cyclic neutropenia and in severe congenital neutropenia.

Yasuhiko Sera1, Hiroshi Kawaguchi, Kazuhiro Nakamura, Takashi Sato, Masakazu Habara, Satoshi Okada, Nobutsune Ishikawa, Seiji Kojima, Osamu Katoh, Masao Kobayashi.   

Abstract

BACKGROUND AND OBJECTIVES: Cyclic neutropenia (CyN) in childhood and severe congenital neutropenia (SCN) are congenital disorders that cause chronic neutropenia. Mutations in the neutrophil elastase gene, ELA2, have been reported in patients with CyN and in those with SCN. We examined granulopoietic defects in CyN patients with those in SCN patients. DESIGN AND METHODS: Three patients with CyN and four with SCN were enrolled in this study. Bone marrow cells were enriched based on the expression of CD34, Kit, and granulocyte colony-stimulating factor receptor (G-CSFR). The purified cells were assayed for colony formation, proliferation, and mRNA expression of granular enzymes.
RESULTS: All patients showed heterozygous mutations of ELA2. Flow cytometric analysis demonstrated no differences in the frequency of CD34, Kit, and G-CSFR expression between CyN patients and normal subjects. Significant differences in granulocyte/macrophage (GM)-colony formation of CD34(+)/Kit(+) cells were observed among CyN patients, SCN patients, and normal subjects in response to hematopoietic factors. Impaired granulopoiesis was found in both CD34(+)/Kit(+)/G-CSFR(+) and CD34(+)/Kit(+)/G-CSFR- cells in patients with CyN, whereas this impairment was observed only in CD34(+)/Kit(+)/G-CSFR(+) cells in SCN patients, as previously reported. The mRNA expression of granular enzymes in myeloid precursors and the transcription levels during myeloid cell differentiation in CyN patients were comparable to those in normal subjects, in contrast to the abnormal transcription of granular enzymes in SCN patients. INTERPRETATION AND
CONCLUSIONS: These results suggest that the underlying granulopoietic abnormalities differ between CyN and SCN, and emphasize the presence of additional genetic pathophysiology specific to each disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16079102

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  7 in total

Review 1.  Neutrophil elastase in cyclic and severe congenital neutropenia.

Authors:  Marshall S Horwitz; Zhijun Duan; Brice Korkmaz; Hu-Hui Lee; Matthew E Mealiffe; Stephen J Salipante
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

2.  Mosaicism of an ELANE mutation in an asymptomatic mother in a familial case of cyclic neutropenia.

Authors:  Osamu Hirata; Satoshi Okada; Miyuki Tsumura; Shuhei Karakawa; Itaru Matsumura; Yujiro Kimura; Toshiro Maihara; Shin'ichiro Yasunaga; Yoshihiro Takihara; Osamu Ohara; Masao Kobayashi
Journal:  J Clin Immunol       Date:  2015-04-26       Impact factor: 8.317

3.  Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia.

Authors:  Jun Xia; Audrey A Bolyard; Elin Rodger; Steve Stein; Andrew A Aprikyan; David C Dale; Daniel C Link
Journal:  Br J Haematol       Date:  2009-09-22       Impact factor: 6.998

Review 4.  ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology.

Authors:  Marshall S Horwitz; Seth J Corey; H Leighton Grimes; Timothy Tidwell
Journal:  Hematol Oncol Clin North Am       Date:  2012-11-07       Impact factor: 3.722

5.  Severe congenital neutropenia in a multigenerational family with a novel neutrophil elastase (ELANE) mutation.

Authors:  Esther van de Vosse; Els M Verhard; Anton J T Tool; Adriëtte W de Visser; Taco W Kuijpers; Pieter S Hiemstra; Jaap T van Dissel
Journal:  Ann Hematol       Date:  2010-08-28       Impact factor: 3.673

6.  Management of tooth extraction in a patient with ELANE gene mutation-induced cyclic neutropenia: A case report.

Authors:  Keiko Aota; Koichi Kani; Tomoko Yamanoi; Yukihiro Momota; Masami Ninomiya; Hiromichi Yumoto; Masayuki Azuma
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

7.  Idiopathic neutropenia of childhood is associated with Fas/FasL expression.

Authors:  Kari C Nadeau; Angel Callejas; Wendy B Wong; Jae Won Joh; Harvey J Cohen; Michael R Jeng
Journal:  Clin Immunol       Date:  2008-09-26       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.